Cover Image
市場調查報告書

心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中產品分析

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358888
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
Back to Top
心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中產品分析 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 108 Pages
簡介

本報告提供現在開發中的心臟再同步化治療──心臟去顫器 (CRT-D)的開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等系統性資訊。

第1章 目錄

第2章 簡介

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D)的概要

第3章 開發中的產品

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各開發階段
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各市場區隔
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各地區
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各法規途徑
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各核準時期 (預定)
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:進行中的臨床實驗

第4章 心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中的開發中產品 (各企業)

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) 企業 - 開發中產品:各開發階段
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各開發階段

第5章 心臟再同步化治療 - 心臟去顫器 (CRT-D) 企業與產品概要

  • Boston Scientific Corp
  • IRadimed
  • John Hopkins University
  • LivaNova PLC
  • Mayo Clinic US
  • Medtronic plc
  • NewPace Ltd
  • St. Jude Medical, Inc.
  • TransWorld Med Corp

第6章 心臟再同步化治療 - 心臟去顫器 (CRT-D) :最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Overview

3. Products under Development

  • 3.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • 3.2. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • 3.3. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
  • 3.4. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
  • 3.5. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials

4. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products under Development by Companies

  • 4.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development

5. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies and Product Overview

  • 5.1. Boston Scientific Corp Company Overview
    • 5.1.1. Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. IRadimed Corp Company Overview
    • 5.2.1. IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. John Hopkins University Company Overview
    • 5.3.1. John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. LivaNova PLC Company Overview
    • 5.4.1. LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Mayo Clinic US Company Overview
    • 5.5.1. Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Medtronic plc Company Overview
    • 5.6.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. NewPace Ltd Company Overview
    • 5.7.1. NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. St. Jude Medical LLC Company Overview
    • 5.8.1. St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. TransWorld Med Corp Company Overview
    • 5.9.1. TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D)- Recent Developments

  • 6.1. May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
  • 6.2. May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer
  • 6.3. May 09, 2017: Boston Scientific Receives U.S. FDA Approval For Resonate Family Of High-Voltage Devices
  • 6.4. May 03, 2017: LivaNova Reports First Quarter 2017 Results
  • 6.5. Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
  • 6.6. Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
  • 6.7. Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
  • 6.8. Mar 16, 2017: NICE Recommends Boston Scientific CRT-D Devices Powered By EnduraLife Battery Technology For Treatment Of Heart Failure
  • 6.9. Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results
  • 6.10. Feb 27, 2017: New Analysis of Reverse Trial Shows Medtronic CRT Devices Cost-Effective, While Helping Patients with Mild Heart Failure Live Longer
  • 6.11. Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange
  • 6.12. Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
  • 6.13. Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
  • 6.14. Feb 06, 2017: Boston scientific launches Resonate family of CRT-D devices in Europe
  • 6.15. Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
  • 6.16. Feb 01, 2017: BIOTRONIK Introduces a Complete CRT Solution with the Ilivia Series
  • 6.17. Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
  • 6.18. Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
  • 6.19. Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
  • 6.20. Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator
  • 6.21. Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester
  • 6.22. Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results
  • 6.23. Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
  • 6.24. Oct 26, 2016: Nihon Kohden Announces Consolidation and Relocation of Offices
  • 6.25. Oct 24, 2016: St. Jude Medical Recalls Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators Due to Premature Battery Depletion
  • 6.26. Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
  • 6.27. Oct 13, 2016: Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging
  • 6.28. Oct 11, 2016: Experts Discuss Clinical Benefits of Closed Loop Stimulation at Heart Rhythm Congress
  • 6.29. Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
  • 6.30. Sep 29, 2016: LivaNova Announces Half-Year Financial Report
  • 6.31. Sep 28, 2016: Hill-Rom Adding More Than 100 Jobs In Central New York
  • 6.32. Sep 22, 2016: LivaNova Launches Next Generation ICD and CRT-D Devices in the United States
  • 6.33. Sep 19, 2016: Analysis Shows Positive Association Between Cardiac Resynchronization Therapy and Patients' Increased Adherence to Heart Failure Medication Regimens
  • 6.34. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.35. Aug 29, 2016: Medtronic Technologies Improve Delivery Of Cardiac Resynchronization Therapy
  • 6.36. Aug 25, 2016: ZOLL LifeVest Wearable Defibrillator Proven Safe and Effective in Largest German Registry
  • 6.37. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.38. Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results
  • 6.39. Aug 01, 2016: LivaNova Names Chief Operating Officer
  • 6.40. Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
  • 6.41. Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors
  • 6.42. Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.43. Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
  • 6.44. Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization
  • 6.45. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.46. Jun 23, 2016: St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
  • 6.47. Jun 10, 2016: 97% One-year Survival for Patients at High Risk of Sudden Cardiac Death Prescribed the ZOLL LifeVest Wearable Defibrillator
  • 6.48. Jun 09, 2016: BIOTRONIK Wins Cardiostim Innovation Award for Best Practice Improvement with MRI AutoDetect Feature
  • 6.49. Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
  • 6.50. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Table 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • Table 3: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
  • Table 4: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials
  • Table 7: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Table 9: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Autogen X4 CRT-D - Product Status
  • Table 11: Autogen X4 CRT-D - Product Description
  • Table 12: CHARISMA X4 - Product Status
  • Table 13: CHARISMA X4 - Product Description
  • Table 14: Next Generation Quad Polar CRT-D - Product Status
  • Table 15: Next Generation Quad Polar CRT-D - Product Description
  • Table 16: NG3 Non Quad System - Product Status
  • Table 17: NG3 Non Quad System - Product Description
  • Table 18: Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Table 19: Autogen X4 CRT-D - Capture Information Via Automatic Threshold Evaluation
  • Table 20: Autogen X4 CRT-D - Expanding MRI Access for Patients with New and Existing ICDs and CRT-Ds (ENABLE MRI)
  • Table 21: Autogen X4 CRT-D - Sleep-disordered Breathing in Patients with Implanted Cardiac Devices: Validation of the Apneascan Algorithm and Implications for Prognosis
  • Table 22: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: MRI Defibrillator - Product Status
  • Table 24: MRI Defibrillator - Product Description
  • Table 25: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Cardiac Arrhythmia Termination Device - Product Status
  • Table 27: Cardiac Arrhythmia Termination Device - Product Description
  • Table 28: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Paradym CRT-D Tri-V Device - Product Status
  • Table 30: Paradym CRT-D Tri-V Device - Product Description
  • Table 31: Paradym RF Platform - Product Status
  • Table 32: Paradym RF Platform - Product Description
  • Table 33: PARADYM RF SonR CRT-D - Product Status
  • Table 34: PARADYM RF SonR CRT-D - Product Description
  • Table 35: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
  • Table 36: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
  • Table 37: LivaNova PLC - Ongoing Clinical Trials Overview
  • Table 38: PARADYM RF SonR CRT-D - Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
  • Table 39: PARADYM RF SonR CRT-D - Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
  • Table 40: Paradym CRT-D Tri-V Device - Triple-site Biventricular Stimulation in the Optimization of Cardiac Resynchronization Therapy (CRT)
  • Table 41: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Atrial Fibrillation Device - Product Status
  • Table 43: Atrial Fibrillation Device - Product Description
  • Table 44: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Amplia MRI Quad CRT-D SureScan System - Product Status
  • Table 46: Amplia MRI Quad CRT-D SureScan System - Product Description
  • Table 47: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
  • Table 48: Amplia MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
  • Table 49: Claria MRI Quad CRT-D SureScan System - Product Status
  • Table 50: Claria MRI Quad CRT-D SureScan System - Product Description
  • Table 51: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Status
  • Table 52: Claria MRI Quad CRT-D SureScan System - Multiple Point Pacing - Product Description
  • Table 53: MRI Safe CRT-D - Product Status
  • Table 54: MRI Safe CRT-D - Product Description
  • Table 55: NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
  • Table 57: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
  • Table 58: NewPace Ltd - Ongoing Clinical Trials Overview
  • Table 59: The Implantable Subcutaneous String Defibrillator (ISSD) - Acute Defibrillation Performance of a Novel Can-less Shock Pathway
  • Table 60: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Quadra Assura MP CRT-D - Product Status
  • Table 62: Quadra Assura MP CRT-D - Product Description
  • Table 63: St. Jude Medical LLC - Ongoing Clinical Trials Overview
  • Table 64: Quadra Assura MP CRT-D - Italian Registry on Multipoint Left Ventricular
  • Table 65: Quadra Assura MP CRT-D - Study Protocol/ Registry of MultiPoint Pacing in Brazil
  • Table 66: TransWorld Med Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Soul Mate - Defibrillator - Product Status
  • Table 68: Soul Mate - Defibrillator - Product Description
  • Table 69: Glossary

List of Figures

  • Figure 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • Figure 3: Cardiac
Back to Top